Last reviewed · How we verify
Synergy for Proteus Meningitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Gentamicin · Merck & Co.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Synergy for Proteus Meningitis patent landscape — cliff calendar, originator estates, attackable patents
- Synergy for Proteus Meningitis treatment landscape brief
- Synergy for Proteus Meningitis treatment updates RSS
Frequently asked questions about Synergy for Proteus Meningitis
What drugs treat Synergy for Proteus Meningitis?
Tracked treatments include Ramycin, Garamycin, Gentamicin.
What is the treatment for Synergy for Proteus Meningitis?
Standard treatment for Synergy for Proteus Meningitis includes Ramycin, Garamycin, Gentamicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Synergy for Proteus Meningitis patent cliff · Synergy for Proteus Meningitis CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Gentamicin · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing